A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)
NCT02119832
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease (CKD)
Interventions
DEVICE:
Endovasccular AVF (EndoAVF)
Sponsor
C. R. Bard